About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in San Francisco | 206 Studies

Clinical Trials Prostate CancerSan Francisco

Prostate Cancer Clinical Trials in San Francisco

Find 206 clinical trials for prostate cancer near San Francisco, California. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in San Francisco

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 181-200 of 206 trials

UnknownStudy of ATN-224 in Patients With Prostate CancerThis is a multicenter, randomized, phase II study of the safety and efficacy of two dose levels of oral ATN-224 in patients with prostate cancer with a rising serum PSA in the…NCT00405574·San Francisco, California and 5 others Active not recruitingA Phase 1-2 Study of ST101 in Patients With Advanced Solid TumorsThis is an open-label, two-part, phase 1-2 dose-finding study designed to determine the safety, tolerability, PK, PD, and proof-of-concept efficacy of ST101 administered IV in…NCT04478279·San Francisco, California and 10 others CompletedAndrogen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or EnzalutamideThis is a prospective, randomized, open-label phase II study comparing cognitive outcomes between men with metastatic and non-metastatic castration resistant prostate cancer…NCT04335682·San Francisco, California and 7 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedKetoconazole and Dexamethasone in Prostate CancerThis is an open label, phase II, single center trial of ketoconazole/dexamethasone to determine if the administration of ketoconazole/dexamethasone, after disease progression with…NCT01036594·San Francisco, California

TerminatedA Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate CancerThere will be two parts to this clinical research study.NCT01717898·San Francisco, California

CompletedA Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene DeficiencyThe purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene deficiency, respond to…NCT02952534·Birmingham, Alabama and 148 others

Terminated11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor ExpressionThis phase I trial studies if positron emission tomography (PET) imaging using 11C-YJH08 can be useful for detecting certain cell receptor expression in tumor cells in patients…NCT04927663·San Francisco, California

CompletedStudy of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate CancerThis study evaluates the diagnostic performance and safety of 18F-DCFPyL (PyL) PET/CT imaging in patients with suspected recurrence of prostate cancer who have negative or…NCT03739684·Duarte, California and 13 others

CompletedWeb-based Lifestyle Trial Among Men With Prostate Cancer: Prostate 8A randomized controlled trial of a technology-based lifestyle intervention vs. usual care among men with low-risk prostate cancer to determine the feasibility and acceptability of…NCT02470936·San Francisco, California

TerminatedGallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid CancerThis pilot clinical trial studies how well Gallium-68 prostate specific membrane antigen positron emission tomography (PET) work in diagnosing patients with thyroid cancer.NCT03463889·San Francisco, California

SuspendedA Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid TumorsThis is a first in human, single arm, open label, Phase 1a/1b study to determine the safety, feasibility, and efficacy of a single dose of NeoTCR-P1 T cells in participants with…NCT03970382·Duarte, California and 8 others

TerminatedSandostatin for Patients With Androgen Independent Prostate CancerThis is an open label, single center Phase II trial of Sandostatin LAR in patients with hormone refractory prostate cancer.NCT00510224·San Francisco, California

CompletedHormone Therapy in Treating Patients With Prostate CancerRATIONALE: Male hormones can stimulate the growth of prostate cancer cells.NCT00003323·Birmingham, Alabama and 42 others

CompletedMENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate CancerThis is a single-arm hybrid implementation trial of men with metastatic castrate-resistant prostate cancer (mCRPC) involving a patient-administered mobile app for consultation…NCT05127850·San Francisco, California

CompletedPembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair DefectsThis is a multicenter phase 2 open label study of pembrolizumab in patients with metastatic castrate resistant prostate cancer (mCRPC) with or without DNA damage repair defects.NCT03248570·San Francisco, California

RecruitingEvaluation of Neoadjuvant Xaluritamig in Localized Prostate CancerThe primary objectives of this study are to evaluate the safety and tolerability of xaluritamig administered as monotherapy or in combination with an oral Gonadotropin-releasing…NCT06613100·San Francisco, California and 8 others

CompletedTPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced CancersThis is a phase 1/1b open label, multicenter dose escalation and dose expansion study to investigate the safety, tolerability and anti-tumor activity of TPST-1120, a small…NCT03829436·San Francisco, California and 10 others

CompletedGallium-68 PSMA-11 PET Imaging in Prostate Cancer PatientsThe investigators are imaging patients with prostate cancer using a new Positron Emission Tomography (PET) imaging agent (Ga-68-PSMA-11) in order to evaluate its ability to detect…NCT03803475·San Francisco, California

CompletedStudy to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates a histopathologic Gleason Score of ≤…NCT02615067·Duarte, California and 44 others

RecruitingFOG-001 in Locally Advanced or Metastatic Solid TumorsThe goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors or in participants with familial…NCT05919264·Phoenix, Arizona and 32 others

PreviousPage 10 of 11Next

Other Conditions in San Francisco

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma